Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
92.4M
-
Number of holders
-
72
-
Total 13F shares, excl. options
-
29.5M
-
Shares change
-
-560K
-
Total reported value, excl. options
-
$13M
-
Value change
-
-$1.28M
-
Number of buys
-
37
-
Number of sells
-
-26
-
Price
-
$0.44
Significant Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q1 2025
90 filings reported holding VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value as of Q1 2025.
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) has 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.5M shares
of 92.4M outstanding shares and own 31.88% of the company stock.
Largest 10 shareholders include Caligan Partners LP (8.99M shares), ARMISTICE CAPITAL, LLC (8.57M shares), BOOTHBAY FUND MANAGEMENT, LLC (2.81M shares), VANGUARD GROUP INC (2.36M shares), BlackRock, Inc. (1.23M shares), GEODE CAPITAL MANAGEMENT, LLC (1.02M shares), UBS Group AG (790K shares), STATE STREET CORP (567K shares), NORTHERN TRUST CORP (435K shares), and MILLENNIUM MANAGEMENT LLC (396K shares).
This table shows the top 72 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.